Interestingly, IDO-1 has been shown to be expressed in tumors from breast, esophageal carcinoma, colorectal cancer, cervical squamous cell carcinoma, melanoma, and pancreatic cancer, and is upregulated by IFN-γ [9]. This evidence concerns the gene IFNG and melanoma.